<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Tilray Inc (NASDAQ: TLRY) has reported Q1 FY22 sales of $168 million, +43% Y/Y, missing the consensus of $172.6 million. The increase was driven by a 38% Y/Y growth in net cannabis revenue to $70 million.
...read full article on Benzinga
